この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1995/4/191 分で読めます
Drug Products Containing Quinine for the Treatment and/or Prevention of Malaria for Over-The-Counter Human Use
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking that would establish that over-the-counter (OTC) drug products containing quinine for the treatment and/or prevention of malaria are not generally recognized as safe and are misbranded. FDA is issuing this notice of proposed rulemaking after considering data and information on the safety of quinine.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →